Biogen Inc. (BIIB) — Stock Analysis & Fair Value

Biogen Inc. (BIIB) trades on NASDAQ at $220.83 (US). Market cap $32.63B. P/E 38.9. P/B 1.7. ROE 4.5%. dividend yield 0.0%. 52-week range $135.39–$225.80.

Sector: Healthcare — Drug Manufacturers - General.

On getValue you can run 9 valuation models on BIIB — DCF, Reverse DCF, Dividend Discount Model (DDM), Cash Flow + IRR, Normalized P/E, Industry Multiple, Piotroski F-Score and NAV — alongside a WACC calculator, up to 10 years of income statement, balance sheet and cash-flow data, peer comparison and insights.

Open the full BIIB analysis · Key metrics & insights

getValue is an analysis tool for education, not investment advice. Figures are shown as reported; model outputs depend on your assumptions.